Search

everythinglearnresearchcommunity

for

Search:↓

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

New therapies for rare skin diseases show promise but need more research.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Sida cordifolia is rich in saponins with antioxidant and antifungal properties.

A new method was developed to purify finasteride for better medical use.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Skin cell clumping for hair growth is improved by a protein called fibronectin, which helps cells stick and move better.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Men and women have different levels and production of brain steroids, which may affect their risk for certain brain disorders.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.